nodes	percent_of_prediction	percent_of_DWPC	metapath
Clodronate—PTGS2—Cisplatin—peripheral nervous system neoplasm	0.111	0.504	CbGbCtD
Clodronate—PTGS2—Etoposide—peripheral nervous system neoplasm	0.109	0.496	CbGbCtD
Clodronate—SLC25A4—Synaptic Vesicle Pathway—SYP—peripheral nervous system neoplasm	0.0211	0.111	CbGpPWpGaD
Clodronate—SLC25A5—Electron Transport Chain—COX2—peripheral nervous system neoplasm	0.0109	0.0576	CbGpPWpGaD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.0102	0.0535	CbGpPWpGaD
Clodronate—SLC25A6—Electron Transport Chain—COX2—peripheral nervous system neoplasm	0.00916	0.0483	CbGpPWpGaD
Clodronate—SLC25A5—Regulation of insulin secretion—SLC2A1—peripheral nervous system neoplasm	0.0073	0.0385	CbGpPWpGaD
Clodronate—SLC25A4—Electron Transport Chain—COX2—peripheral nervous system neoplasm	0.00715	0.0377	CbGpPWpGaD
Clodronate—SLC25A6—Regulation of insulin secretion—SLC2A1—peripheral nervous system neoplasm	0.00612	0.0323	CbGpPWpGaD
Clodronate—SLC25A5—Regulation of insulin secretion—GNAS—peripheral nervous system neoplasm	0.00588	0.031	CbGpPWpGaD
Clodronate—SLC25A5—Integration of energy metabolism—SLC2A1—peripheral nervous system neoplasm	0.00574	0.0303	CbGpPWpGaD
Clodronate—SLC25A6—Regulation of insulin secretion—GNAS—peripheral nervous system neoplasm	0.00492	0.0259	CbGpPWpGaD
Clodronate—SLC25A6—Integration of energy metabolism—SLC2A1—peripheral nervous system neoplasm	0.00481	0.0254	CbGpPWpGaD
Clodronate—SLC25A4—Regulation of insulin secretion—SLC2A1—peripheral nervous system neoplasm	0.00478	0.0252	CbGpPWpGaD
Clodronate—SLC25A5—Integration of energy metabolism—GNAS—peripheral nervous system neoplasm	0.00462	0.0243	CbGpPWpGaD
Clodronate—SLC25A6—Integration of energy metabolism—GNAS—peripheral nervous system neoplasm	0.00387	0.0204	CbGpPWpGaD
Clodronate—SLC25A4—Regulation of insulin secretion—GNAS—peripheral nervous system neoplasm	0.00384	0.0203	CbGpPWpGaD
Clodronate—SLC25A4—Integration of energy metabolism—SLC2A1—peripheral nervous system neoplasm	0.00376	0.0198	CbGpPWpGaD
Clodronate—SLC25A4—Vitamin A—Isotretinoin—peripheral nervous system neoplasm	0.00335	0.135	CbGdCrCtD
Clodronate—SLC25A4—Vitamin A—Tretinoin—peripheral nervous system neoplasm	0.00335	0.135	CbGdCrCtD
Clodronate—SLC25A4—Integration of energy metabolism—GNAS—peripheral nervous system neoplasm	0.00302	0.0159	CbGpPWpGaD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.00292	0.0154	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00275	0.0145	CbGpPWpGaD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.00268	0.0141	CbGpPWpGaD
Clodronate—SLC25A6—Vinorelbine—Vincristine—peripheral nervous system neoplasm	0.00265	0.107	CbGdCrCtD
Clodronate—SLC25A4—Vitamin A—Alitretinoin—peripheral nervous system neoplasm	0.00254	0.102	CbGdCrCtD
Clodronate—SLC25A4—Alitretinoin—Tretinoin—peripheral nervous system neoplasm	0.00234	0.0944	CbGdCrCtD
Clodronate—SLC25A4—Isotretinoin—Tretinoin—peripheral nervous system neoplasm	0.00234	0.0944	CbGdCrCtD
Clodronate—SLC25A4—Tretinoin—Isotretinoin—peripheral nervous system neoplasm	0.00234	0.0944	CbGdCrCtD
Clodronate—SLC25A4—Alitretinoin—Isotretinoin—peripheral nervous system neoplasm	0.00234	0.0944	CbGdCrCtD
Clodronate—SLC25A6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00231	0.0122	CbGpPWpGaD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.00218	0.0115	CbGpPWpGaD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—NF1—peripheral nervous system neoplasm	0.00212	0.0112	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00186	0.0098	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.0018	0.00949	CbGpPWpGaD
Clodronate—SLC25A4—Tretinoin—Alitretinoin—peripheral nervous system neoplasm	0.00178	0.0716	CbGdCrCtD
Clodronate—SLC25A4—Isotretinoin—Alitretinoin—peripheral nervous system neoplasm	0.00178	0.0716	CbGdCrCtD
Clodronate—Urethral disorder—Isotretinoin—peripheral nervous system neoplasm	0.00163	0.00288	CcSEcCtD
Clodronate—Urinary tract disorder—Melphalan—peripheral nervous system neoplasm	0.00162	0.00286	CcSEcCtD
Clodronate—Connective tissue disorder—Melphalan—peripheral nervous system neoplasm	0.00161	0.00285	CcSEcCtD
Clodronate—Urethral disorder—Melphalan—peripheral nervous system neoplasm	0.00161	0.00284	CcSEcCtD
Clodronate—SLC25A5—Disease—GNS—peripheral nervous system neoplasm	0.00161	0.00846	CbGpPWpGaD
Clodronate—Hypercalcaemia—Epirubicin—peripheral nervous system neoplasm	0.00158	0.00279	CcSEcCtD
Clodronate—Dysphagia—Alitretinoin—peripheral nervous system neoplasm	0.00157	0.00278	CcSEcCtD
Clodronate—SLC25A6—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00156	0.00821	CbGpPWpGaD
Clodronate—Bronchospasm—Alitretinoin—peripheral nervous system neoplasm	0.00155	0.00274	CcSEcCtD
Clodronate—Pneumonia—Dactinomycin—peripheral nervous system neoplasm	0.00152	0.00269	CcSEcCtD
Clodronate—Mediastinal disorder—Topotecan—peripheral nervous system neoplasm	0.00151	0.00267	CcSEcCtD
Clodronate—Mediastinal disorder—Melphalan—peripheral nervous system neoplasm	0.00148	0.00261	CcSEcCtD
Clodronate—Hypercalcaemia—Doxorubicin—peripheral nervous system neoplasm	0.00146	0.00258	CcSEcCtD
Clodronate—Cardiac failure—Etoposide—peripheral nervous system neoplasm	0.00146	0.00257	CcSEcCtD
Clodronate—Blood creatinine increased—Cisplatin—peripheral nervous system neoplasm	0.00145	0.00257	CcSEcCtD
Clodronate—Dehydration—Cisplatin—peripheral nervous system neoplasm	0.00144	0.00255	CcSEcCtD
Clodronate—Pneumonia—Alitretinoin—peripheral nervous system neoplasm	0.00141	0.00249	CcSEcCtD
Clodronate—Renal failure—Alitretinoin—peripheral nervous system neoplasm	0.00138	0.00244	CcSEcCtD
Clodronate—Pneumonia—Vincristine—peripheral nervous system neoplasm	0.00136	0.0024	CcSEcCtD
Clodronate—Pharyngitis—Dactinomycin—peripheral nervous system neoplasm	0.00135	0.00238	CcSEcCtD
Clodronate—Anaemia—Topotecan—peripheral nervous system neoplasm	0.00135	0.00238	CcSEcCtD
Clodronate—SLC25A6—Disease—GNS—peripheral nervous system neoplasm	0.00135	0.00709	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—GNS—peripheral nervous system neoplasm	0.00134	0.00709	CbGpPWpGaD
Clodronate—Anaemia—Tretinoin—peripheral nervous system neoplasm	0.00134	0.00236	CcSEcCtD
Clodronate—Anaemia—Isotretinoin—peripheral nervous system neoplasm	0.00134	0.00236	CcSEcCtD
Clodronate—Angioedema—Topotecan—peripheral nervous system neoplasm	0.00133	0.00236	CcSEcCtD
Clodronate—Anaemia—Melphalan—peripheral nervous system neoplasm	0.00132	0.00233	CcSEcCtD
Clodronate—PTGS2—C-MYB transcription factor network—CD34—peripheral nervous system neoplasm	0.00131	0.00691	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—NME1—peripheral nervous system neoplasm	0.00129	0.00679	CbGpPWpGaD
Clodronate—Neoplasm malignant—Epirubicin—peripheral nervous system neoplasm	0.00129	0.00227	CcSEcCtD
Clodronate—Extravasation—Epirubicin—peripheral nervous system neoplasm	0.00126	0.00222	CcSEcCtD
Clodronate—Alanine aminotransferase increased—Etoposide—peripheral nervous system neoplasm	0.00125	0.00222	CcSEcCtD
Clodronate—Pharyngitis—Alitretinoin—peripheral nervous system neoplasm	0.00125	0.00221	CcSEcCtD
Clodronate—Urinary tract disorder—Alitretinoin—peripheral nervous system neoplasm	0.00124	0.0022	CcSEcCtD
Clodronate—SLC25A5—Metabolism—COX2—peripheral nervous system neoplasm	0.00124	0.00654	CbGpPWpGaD
Clodronate—Urethral disorder—Alitretinoin—peripheral nervous system neoplasm	0.00124	0.00218	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Topotecan—peripheral nervous system neoplasm	0.00123	0.00218	CcSEcCtD
Clodronate—Dysphagia—Etoposide—peripheral nervous system neoplasm	0.00123	0.00217	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Tretinoin—peripheral nervous system neoplasm	0.00122	0.00216	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Isotretinoin—peripheral nervous system neoplasm	0.00122	0.00216	CcSEcCtD
Clodronate—SLC25A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00122	0.00641	CbGpPWpGaD
Clodronate—Bronchospasm—Etoposide—peripheral nervous system neoplasm	0.00121	0.00214	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Melphalan—peripheral nervous system neoplasm	0.00121	0.00213	CcSEcCtD
Clodronate—Hypocalcaemia—Epirubicin—peripheral nervous system neoplasm	0.0012	0.00212	CcSEcCtD
Clodronate—Urinary tract disorder—Vincristine—peripheral nervous system neoplasm	0.0012	0.00212	CcSEcCtD
Clodronate—Connective tissue disorder—Vincristine—peripheral nervous system neoplasm	0.00119	0.00211	CcSEcCtD
Clodronate—Oliguria—Epirubicin—peripheral nervous system neoplasm	0.00119	0.0021	CcSEcCtD
Clodronate—Urethral disorder—Vincristine—peripheral nervous system neoplasm	0.00119	0.0021	CcSEcCtD
Clodronate—Neoplasm malignant—Doxorubicin—peripheral nervous system neoplasm	0.00119	0.0021	CcSEcCtD
Clodronate—Infection—Topotecan—peripheral nervous system neoplasm	0.00118	0.00209	CcSEcCtD
Clodronate—Renal failure—Cisplatin—peripheral nervous system neoplasm	0.00118	0.00208	CcSEcCtD
Clodronate—Infection—Tretinoin—peripheral nervous system neoplasm	0.00117	0.00207	CcSEcCtD
Clodronate—Infection—Isotretinoin—peripheral nervous system neoplasm	0.00117	0.00207	CcSEcCtD
Clodronate—Extravasation—Doxorubicin—peripheral nervous system neoplasm	0.00116	0.00206	CcSEcCtD
Clodronate—Infection—Melphalan—peripheral nervous system neoplasm	0.00116	0.00205	CcSEcCtD
Clodronate—Skin disorder—Topotecan—peripheral nervous system neoplasm	0.00116	0.00204	CcSEcCtD
Clodronate—Creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.00115	0.00204	CcSEcCtD
Clodronate—Skin disorder—Tretinoin—peripheral nervous system neoplasm	0.00115	0.00203	CcSEcCtD
Clodronate—Skin disorder—Isotretinoin—peripheral nervous system neoplasm	0.00115	0.00203	CcSEcCtD
Clodronate—Anorexia—Topotecan—peripheral nervous system neoplasm	0.00114	0.00201	CcSEcCtD
Clodronate—Skin disorder—Melphalan—peripheral nervous system neoplasm	0.00113	0.002	CcSEcCtD
Clodronate—SLC25A6—Metabolism—GNS—peripheral nervous system neoplasm	0.00113	0.00594	CbGpPWpGaD
Clodronate—Anorexia—Isotretinoin—peripheral nervous system neoplasm	0.00113	0.00199	CcSEcCtD
Clodronate—Anorexia—Tretinoin—peripheral nervous system neoplasm	0.00113	0.00199	CcSEcCtD
Clodronate—SLC25A5—Disease—PPP3R1—peripheral nervous system neoplasm	0.00112	0.00592	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism of proteins—BCHE—peripheral nervous system neoplasm	0.00112	0.0059	CbGpPWpGaD
Clodronate—Anorexia—Melphalan—peripheral nervous system neoplasm	0.00111	0.00196	CcSEcCtD
Clodronate—Hypocalcaemia—Doxorubicin—peripheral nervous system neoplasm	0.00111	0.00196	CcSEcCtD
Clodronate—Oliguria—Doxorubicin—peripheral nervous system neoplasm	0.0011	0.00195	CcSEcCtD
Clodronate—Pneumonia—Etoposide—peripheral nervous system neoplasm	0.0011	0.00195	CcSEcCtD
Clodronate—Hepatocellular injury—Epirubicin—peripheral nervous system neoplasm	0.0011	0.00194	CcSEcCtD
Clodronate—Mediastinal disorder—Vincristine—peripheral nervous system neoplasm	0.00109	0.00193	CcSEcCtD
Clodronate—Anaemia—Dactinomycin—peripheral nervous system neoplasm	0.00109	0.00193	CcSEcCtD
Clodronate—SLC25A4—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.00109	0.00574	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—NME1—peripheral nervous system neoplasm	0.00108	0.00569	CbGpPWpGaD
Clodronate—Renal failure—Etoposide—peripheral nervous system neoplasm	0.00108	0.0019	CcSEcCtD
Clodronate—Creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.00107	0.00189	CcSEcCtD
Clodronate—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.00106	0.00188	CcSEcCtD
Clodronate—Urinary tract disorder—Cisplatin—peripheral nervous system neoplasm	0.00106	0.00187	CcSEcCtD
Clodronate—Connective tissue disorder—Cisplatin—peripheral nervous system neoplasm	0.00106	0.00186	CcSEcCtD
Clodronate—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.00105	0.00186	CcSEcCtD
Clodronate—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.00105	0.00186	CcSEcCtD
Clodronate—Urethral disorder—Cisplatin—peripheral nervous system neoplasm	0.00105	0.00186	CcSEcCtD
Clodronate—SLC25A4—Disease—GNS—peripheral nervous system neoplasm	0.00105	0.00553	CbGpPWpGaD
Clodronate—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.00105	0.00185	CcSEcCtD
Clodronate—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.00104	0.00184	CcSEcCtD
Clodronate—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.00104	0.00184	CcSEcCtD
Clodronate—SLC25A6—Metabolism—COX2—peripheral nervous system neoplasm	0.00104	0.00548	CbGpPWpGaD
Clodronate—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.00104	0.00184	CcSEcCtD
Clodronate—Decreased appetite—Topotecan—peripheral nervous system neoplasm	0.00104	0.00183	CcSEcCtD
Clodronate—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.00103	0.00182	CcSEcCtD
Clodronate—Decreased appetite—Isotretinoin—peripheral nervous system neoplasm	0.00103	0.00181	CcSEcCtD
Clodronate—Decreased appetite—Tretinoin—peripheral nervous system neoplasm	0.00103	0.00181	CcSEcCtD
Clodronate—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.00103	0.00181	CcSEcCtD
Clodronate—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.00102	0.0018	CcSEcCtD
Clodronate—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.00102	0.0018	CcSEcCtD
Clodronate—Hepatocellular injury—Doxorubicin—peripheral nervous system neoplasm	0.00102	0.00179	CcSEcCtD
Clodronate—Anaemia—Alitretinoin—peripheral nervous system neoplasm	0.00101	0.00179	CcSEcCtD
Clodronate—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.00101	0.00179	CcSEcCtD
Clodronate—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.00101	0.00178	CcSEcCtD
Clodronate—Anaemia—Vincristine—peripheral nervous system neoplasm	0.000977	0.00173	CcSEcCtD
Clodronate—SLC25A5—Disease—ENO2—peripheral nervous system neoplasm	0.000973	0.00513	CbGpPWpGaD
Clodronate—Urinary tract disorder—Etoposide—peripheral nervous system neoplasm	0.000972	0.00172	CcSEcCtD
Clodronate—Mediastinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000968	0.00171	CcSEcCtD
Clodronate—Urethral disorder—Etoposide—peripheral nervous system neoplasm	0.000965	0.0017	CcSEcCtD
Clodronate—Infection—Dactinomycin—peripheral nervous system neoplasm	0.00096	0.00169	CcSEcCtD
Clodronate—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000946	0.00167	CcSEcCtD
Clodronate—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.000942	0.00166	CcSEcCtD
Clodronate—SLC25A6—Disease—PPP3R1—peripheral nervous system neoplasm	0.000941	0.00496	CbGpPWpGaD
Clodronate—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.000939	0.00166	CcSEcCtD
Clodronate—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.000939	0.00166	CcSEcCtD
Clodronate—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000934	0.00165	CcSEcCtD
Clodronate—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000934	0.00165	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.000928	0.00164	CcSEcCtD
Clodronate—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000927	0.00164	CcSEcCtD
Clodronate—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.000921	0.00163	CcSEcCtD
Clodronate—Hepatic function abnormal—Epirubicin—peripheral nervous system neoplasm	0.000912	0.00161	CcSEcCtD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.000897	0.00472	CbGpPWpGaD
Clodronate—Infection—Alitretinoin—peripheral nervous system neoplasm	0.00089	0.00157	CcSEcCtD
Clodronate—Mediastinal disorder—Etoposide—peripheral nervous system neoplasm	0.000887	0.00157	CcSEcCtD
Clodronate—SLC25A4—Metabolism—GNS—peripheral nervous system neoplasm	0.00088	0.00464	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism of proteins—BCHE—peripheral nervous system neoplasm	0.000874	0.0046	CbGpPWpGaD
Clodronate—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.00087	0.00154	CcSEcCtD
Clodronate—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.000864	0.00153	CcSEcCtD
Clodronate—Renal failure acute—Epirubicin—peripheral nervous system neoplasm	0.000864	0.00152	CcSEcCtD
Clodronate—Infection—Vincristine—peripheral nervous system neoplasm	0.000857	0.00151	CcSEcCtD
Clodronate—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A1—peripheral nervous system neoplasm	0.000857	0.00451	CbGpPWpGaD
Clodronate—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000854	0.00151	CcSEcCtD
Clodronate—Hepatic function abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000844	0.00149	CcSEcCtD
Clodronate—SLC25A4—Metabolism—NME1—peripheral nervous system neoplasm	0.000843	0.00444	CbGpPWpGaD
Clodronate—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000843	0.00149	CcSEcCtD
Clodronate—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.00084	0.00148	CcSEcCtD
Clodronate—Renal impairment—Epirubicin—peripheral nervous system neoplasm	0.000838	0.00148	CcSEcCtD
Clodronate—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000836	0.00148	CcSEcCtD
Clodronate—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000836	0.00148	CcSEcCtD
Clodronate—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000825	0.00146	CcSEcCtD
Clodronate—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000823	0.00145	CcSEcCtD
Clodronate—Cardiac failure—Epirubicin—peripheral nervous system neoplasm	0.000817	0.00144	CcSEcCtD
Clodronate—SLC25A6—Disease—ENO2—peripheral nervous system neoplasm	0.000815	0.0043	CbGpPWpGaD
Clodronate—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000815	0.00144	CcSEcCtD
Clodronate—SLC25A5—Metabolism—ENO2—peripheral nervous system neoplasm	0.000815	0.00429	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—COX2—peripheral nervous system neoplasm	0.000812	0.00428	CbGpPWpGaD
Clodronate—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000809	0.00143	CcSEcCtD
Clodronate—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000809	0.00143	CcSEcCtD
Clodronate—Renal failure acute—Doxorubicin—peripheral nervous system neoplasm	0.000799	0.00141	CcSEcCtD
Clodronate—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000798	0.00141	CcSEcCtD
Clodronate—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000798	0.00141	CcSEcCtD
Clodronate—Anaemia—Etoposide—peripheral nervous system neoplasm	0.000792	0.0014	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000791	0.0014	CcSEcCtD
Clodronate—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000788	0.00139	CcSEcCtD
Clodronate—SLC25A5—Disease—SLC2A1—peripheral nervous system neoplasm	0.000784	0.00413	CbGpPWpGaD
Clodronate—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000779	0.00137	CcSEcCtD
Clodronate—Renal impairment—Doxorubicin—peripheral nervous system neoplasm	0.000775	0.00137	CcSEcCtD
Clodronate—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000773	0.00137	CcSEcCtD
Clodronate—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000764	0.00135	CcSEcCtD
Clodronate—Infection—Cisplatin—peripheral nervous system neoplasm	0.000758	0.00134	CcSEcCtD
Clodronate—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000757	0.00134	CcSEcCtD
Clodronate—Cardiac failure—Doxorubicin—peripheral nervous system neoplasm	0.000756	0.00133	CcSEcCtD
Clodronate—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000751	0.00133	CcSEcCtD
Clodronate—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000751	0.00133	CcSEcCtD
Clodronate—Rash—Topotecan—peripheral nervous system neoplasm	0.000751	0.00133	CcSEcCtD
Clodronate—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00075	0.00133	CcSEcCtD
Clodronate—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00075	0.00132	CcSEcCtD
Clodronate—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.000747	0.00132	CcSEcCtD
Clodronate—Rash—Tretinoin—peripheral nervous system neoplasm	0.000745	0.00132	CcSEcCtD
Clodronate—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000745	0.00132	CcSEcCtD
Clodronate—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000745	0.00132	CcSEcCtD
Clodronate—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000744	0.00131	CcSEcCtD
Clodronate—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000744	0.00131	CcSEcCtD
Clodronate—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000742	0.00131	CcSEcCtD
Clodronate—Dehydration—Epirubicin—peripheral nervous system neoplasm	0.000741	0.00131	CcSEcCtD
Clodronate—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000741	0.00131	CcSEcCtD
Clodronate—Rash—Melphalan—peripheral nervous system neoplasm	0.000735	0.0013	CcSEcCtD
Clodronate—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000735	0.0013	CcSEcCtD
Clodronate—SLC25A4—Disease—PPP3R1—peripheral nervous system neoplasm	0.000735	0.00387	CbGpPWpGaD
Clodronate—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.000728	0.00129	CcSEcCtD
Clodronate—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000727	0.00128	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000724	0.00128	CcSEcCtD
Clodronate—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000711	0.00126	CcSEcCtD
Clodronate—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000708	0.00125	CcSEcCtD
Clodronate—Nausea—Topotecan—peripheral nervous system neoplasm	0.000708	0.00125	CcSEcCtD
Clodronate—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000703	0.00124	CcSEcCtD
Clodronate—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000702	0.00124	CcSEcCtD
Clodronate—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000702	0.00124	CcSEcCtD
Clodronate—Infection—Etoposide—peripheral nervous system neoplasm	0.000694	0.00123	CcSEcCtD
Clodronate—Nausea—Melphalan—peripheral nervous system neoplasm	0.000693	0.00122	CcSEcCtD
Clodronate—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000691	0.00122	CcSEcCtD
Clodronate—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000689	0.00122	CcSEcCtD
Clodronate—SLC25A5—Metabolism—BCHE—peripheral nervous system neoplasm	0.000688	0.00363	CbGpPWpGaD
Clodronate—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.000686	0.00121	CcSEcCtD
Clodronate—SLC25A6—Metabolism—ENO2—peripheral nervous system neoplasm	0.000683	0.0036	CbGpPWpGaD
Clodronate—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000682	0.0012	CcSEcCtD
Clodronate—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00068	0.0012	CcSEcCtD
Clodronate—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000679	0.0012	CcSEcCtD
Clodronate—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000674	0.00119	CcSEcCtD
Clodronate—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000666	0.00118	CcSEcCtD
Clodronate—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000663	0.00117	CcSEcCtD
Clodronate—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000661	0.00117	CcSEcCtD
Clodronate—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000659	0.00116	CcSEcCtD
Clodronate—SLC25A6—Disease—SLC2A1—peripheral nervous system neoplasm	0.000657	0.00346	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000657	0.00346	CbGpPWpGaD
Clodronate—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000651	0.00115	CcSEcCtD
Clodronate—SLC25A5—Metabolism—TH—peripheral nervous system neoplasm	0.000647	0.00341	CbGpPWpGaD
Clodronate—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000638	0.00113	CcSEcCtD
Clodronate—SLC25A4—Disease—ENO2—peripheral nervous system neoplasm	0.000636	0.00335	CbGpPWpGaD
Clodronate—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000634	0.00112	CcSEcCtD
Clodronate—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000623	0.0011	CcSEcCtD
Clodronate—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000618	0.00109	CcSEcCtD
Clodronate—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000614	0.00108	CcSEcCtD
Clodronate—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000613	0.00108	CcSEcCtD
Clodronate—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000609	0.00108	CcSEcCtD
Clodronate—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000608	0.00107	CcSEcCtD
Clodronate—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000604	0.00107	CcSEcCtD
Clodronate—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000604	0.00107	CcSEcCtD
Clodronate—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00059	0.00104	CcSEcCtD
Clodronate—SLC25A6—Metabolism—BCHE—peripheral nervous system neoplasm	0.000577	0.00304	CbGpPWpGaD
Clodronate—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000574	0.00101	CcSEcCtD
Clodronate—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000572	0.00101	CcSEcCtD
Clodronate—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000569	0.00101	CcSEcCtD
Clodronate—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000565	0.000997	CcSEcCtD
Clodronate—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000564	0.000996	CcSEcCtD
Clodronate—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000559	0.000987	CcSEcCtD
Clodronate—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000555	0.000981	CcSEcCtD
Clodronate—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000553	0.000976	CcSEcCtD
Clodronate—SLC25A6—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.00055	0.0029	CbGpPWpGaD
Clodronate—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000549	0.000969	CcSEcCtD
Clodronate—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000547	0.000967	CcSEcCtD
Clodronate—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000545	0.000962	CcSEcCtD
Clodronate—Rash—Vincristine—peripheral nervous system neoplasm	0.000544	0.000961	CcSEcCtD
Clodronate—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000544	0.00096	CcSEcCtD
Clodronate—SLC25A6—Metabolism—TH—peripheral nervous system neoplasm	0.000542	0.00286	CbGpPWpGaD
Clodronate—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000542	0.000957	CcSEcCtD
Clodronate—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000541	0.000955	CcSEcCtD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.00054	0.00285	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—BDNF—peripheral nervous system neoplasm	0.000539	0.00284	CbGpPWpGaD
Clodronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—peripheral nervous system neoplasm	0.000535	0.00282	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—ENO2—peripheral nervous system neoplasm	0.000533	0.00281	CbGpPWpGaD
Clodronate—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000532	0.000939	CcSEcCtD
Clodronate—SLC25A5—Metabolism—GNAS—peripheral nervous system neoplasm	0.000528	0.00278	CbGpPWpGaD
Clodronate—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000522	0.000922	CcSEcCtD
Clodronate—SLC25A5—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000518	0.00273	CbGpPWpGaD
Clodronate—SLC25A4—Disease—SLC2A1—peripheral nervous system neoplasm	0.000513	0.0027	CbGpPWpGaD
Clodronate—Nausea—Vincristine—peripheral nervous system neoplasm	0.000513	0.000905	CcSEcCtD
Clodronate—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000507	0.000894	CcSEcCtD
Clodronate—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000504	0.00089	CcSEcCtD
Clodronate—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000502	0.000886	CcSEcCtD
Clodronate—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.0005	0.000883	CcSEcCtD
Clodronate—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000497	0.000878	CcSEcCtD
Clodronate—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000495	0.000873	CcSEcCtD
Clodronate—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000485	0.000857	CcSEcCtD
Clodronate—Rash—Cisplatin—peripheral nervous system neoplasm	0.000481	0.00085	CcSEcCtD
Clodronate—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000481	0.000849	CcSEcCtD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	0.00048	0.00253	CbGpPWpGaD
Clodronate—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000478	0.000845	CcSEcCtD
Clodronate—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.00046	0.000812	CcSEcCtD
Clodronate—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—peripheral nervous system neoplasm	0.000456	0.00241	CbGpPWpGaD
Clodronate—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000453	0.0008	CcSEcCtD
Clodronate—SLC25A4—Metabolism—BCHE—peripheral nervous system neoplasm	0.00045	0.00237	CbGpPWpGaD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	0.000447	0.00235	CbGpPWpGaD
Clodronate—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000444	0.000785	CcSEcCtD
Clodronate—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000444	0.000784	CcSEcCtD
Clodronate—SLC25A6—Metabolism—GNAS—peripheral nervous system neoplasm	0.000443	0.00233	CbGpPWpGaD
Clodronate—Rash—Etoposide—peripheral nervous system neoplasm	0.000441	0.000778	CcSEcCtD
Clodronate—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00044	0.000778	CcSEcCtD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000439	0.00231	CbGpPWpGaD
Clodronate—SLC25A5—Disease—PTPN11—peripheral nervous system neoplasm	0.000438	0.00231	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000434	0.00229	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.00043	0.00226	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—TH—peripheral nervous system neoplasm	0.000423	0.00223	CbGpPWpGaD
Clodronate—Nausea—Etoposide—peripheral nervous system neoplasm	0.000415	0.000733	CcSEcCtD
Clodronate—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000411	0.000725	CcSEcCtD
Clodronate—PTGS2—C-MYB transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.000407	0.00215	CbGpPWpGaD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000406	0.000717	CcSEcCtD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.0004	0.00211	CbGpPWpGaD
Clodronate—Infection—Epirubicin—peripheral nervous system neoplasm	0.000389	0.000687	CcSEcCtD
Clodronate—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000381	0.000672	CcSEcCtD
Clodronate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000376	0.000663	CcSEcCtD
Clodronate—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000374	0.00066	CcSEcCtD
Clodronate—SLC25A6—Disease—PTPN11—peripheral nervous system neoplasm	0.000367	0.00194	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.000367	0.00193	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	0.000361	0.0019	CbGpPWpGaD
Clodronate—Infection—Doxorubicin—peripheral nervous system neoplasm	0.00036	0.000636	CcSEcCtD
Clodronate—PTGS2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000356	0.00188	CbGpPWpGaD
Clodronate—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000352	0.000622	CcSEcCtD
Clodronate—PTGS2—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	0.000351	0.00185	CbGpPWpGaD
Clodronate—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000349	0.000617	CcSEcCtD
Clodronate—SLC25A5—Disease—ERBB2—peripheral nervous system neoplasm	0.000346	0.00183	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—GNAS—peripheral nervous system neoplasm	0.000346	0.00182	CbGpPWpGaD
Clodronate—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000346	0.00061	CcSEcCtD
Clodronate—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000345	0.000609	CcSEcCtD
Clodronate—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000341	0.000601	CcSEcCtD
Clodronate—SLC25A4—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000339	0.00179	CbGpPWpGaD
Clodronate—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000338	0.000597	CcSEcCtD
Clodronate—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000323	0.000571	CcSEcCtD
Clodronate—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000319	0.000564	CcSEcCtD
Clodronate—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000315	0.000557	CcSEcCtD
Clodronate—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000313	0.000553	CcSEcCtD
Clodronate—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000311	0.00055	CcSEcCtD
Clodronate—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.00031	0.000547	CcSEcCtD
Clodronate—PTGS2—C-MYB transcription factor network—NRAS—peripheral nervous system neoplasm	0.000296	0.00156	CbGpPWpGaD
Clodronate—SLC25A6—Disease—ERBB2—peripheral nervous system neoplasm	0.00029	0.00153	CbGpPWpGaD
Clodronate—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000288	0.000509	CcSEcCtD
Clodronate—SLC25A4—Disease—PTPN11—peripheral nervous system neoplasm	0.000287	0.00151	CbGpPWpGaD
Clodronate—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000287	0.000506	CcSEcCtD
Clodronate—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000277	0.00049	CcSEcCtD
Clodronate—PTGS2—C-MYB transcription factor network—MYC—peripheral nervous system neoplasm	0.000276	0.00145	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—CASP3—peripheral nervous system neoplasm	0.000269	0.00142	CbGpPWpGaD
Clodronate—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000268	0.000473	CcSEcCtD
Clodronate—SLC25A5—Disease—NRAS—peripheral nervous system neoplasm	0.000264	0.00139	CbGpPWpGaD
Clodronate—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000257	0.000453	CcSEcCtD
Clodronate—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000249	0.00044	CcSEcCtD
Clodronate—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.000438	CcSEcCtD
Clodronate—Rash—Epirubicin—peripheral nervous system neoplasm	0.000247	0.000436	CcSEcCtD
Clodronate—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000247	0.000436	CcSEcCtD
Clodronate—SLC25A5—Disease—MYC—peripheral nervous system neoplasm	0.000246	0.00129	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000241	0.00127	CbGpPWpGaD
Clodronate—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000233	0.000411	CcSEcCtD
Clodronate—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000231	0.000407	CcSEcCtD
Clodronate—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.000404	CcSEcCtD
Clodronate—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.000403	CcSEcCtD
Clodronate—SLC25A4—Disease—ERBB2—peripheral nervous system neoplasm	0.000227	0.00119	CbGpPWpGaD
Clodronate—SLC25A6—Disease—NRAS—peripheral nervous system neoplasm	0.000221	0.00116	CbGpPWpGaD
Clodronate—PTGS2—C-MYB transcription factor network—HRAS—peripheral nervous system neoplasm	0.000217	0.00114	CbGpPWpGaD
Clodronate—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.00038	CcSEcCtD
Clodronate—PTGS2—Spinal Cord Injury—MYC—peripheral nervous system neoplasm	0.00021	0.00111	CbGpPWpGaD
Clodronate—PTGS2—Disease—GNS—peripheral nervous system neoplasm	0.000208	0.00109	CbGpPWpGaD
Clodronate—SLC25A6—Disease—MYC—peripheral nervous system neoplasm	0.000206	0.00108	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	0.000202	0.00106	CbGpPWpGaD
Clodronate—PTGS2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.0002	0.00105	CbGpPWpGaD
Clodronate—SLC25A5—Disease—HRAS—peripheral nervous system neoplasm	0.000193	0.00102	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000183	0.000965	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GNS—peripheral nervous system neoplasm	0.000174	0.000916	CbGpPWpGaD
Clodronate—PTGS2—Spinal Cord Injury—TP53—peripheral nervous system neoplasm	0.000173	0.00091	CbGpPWpGaD
Clodronate—SLC25A4—Disease—NRAS—peripheral nervous system neoplasm	0.000172	0.000909	CbGpPWpGaD
Clodronate—SLC25A5—Disease—AKT1—peripheral nervous system neoplasm	0.00017	0.000897	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—NME1—peripheral nervous system neoplasm	0.000167	0.000879	CbGpPWpGaD
Clodronate—SLC25A6—Disease—HRAS—peripheral nervous system neoplasm	0.000162	0.000852	CbGpPWpGaD
Clodronate—SLC25A4—Disease—MYC—peripheral nervous system neoplasm	0.000161	0.000846	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—COX2—peripheral nervous system neoplasm	0.000161	0.000846	CbGpPWpGaD
Clodronate—PTGS2—Disease—PPP3R1—peripheral nervous system neoplasm	0.000145	0.000765	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000143	0.000754	CbGpPWpGaD
Clodronate—SLC25A6—Disease—AKT1—peripheral nervous system neoplasm	0.000143	0.000752	CbGpPWpGaD
Clodronate—SLC25A5—Metabolism—AKT1—peripheral nervous system neoplasm	0.000143	0.000751	CbGpPWpGaD
Clodronate—SLC25A4—Disease—HRAS—peripheral nervous system neoplasm	0.000126	0.000665	CbGpPWpGaD
Clodronate—PTGS2—Disease—ENO2—peripheral nervous system neoplasm	0.000126	0.000663	CbGpPWpGaD
Clodronate—SLC25A6—Metabolism—AKT1—peripheral nervous system neoplasm	0.00012	0.00063	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	0.000117	0.000619	CbGpPWpGaD
Clodronate—SLC25A4—Disease—AKT1—peripheral nervous system neoplasm	0.000111	0.000587	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ENO2—peripheral nervous system neoplasm	0.000105	0.000555	CbGpPWpGaD
Clodronate—PTGS2—Disease—SLC2A1—peripheral nervous system neoplasm	0.000101	0.000534	CbGpPWpGaD
Clodronate—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	9.92e-05	0.000523	CbGpPWpGaD
Clodronate—SLC25A4—Metabolism—AKT1—peripheral nervous system neoplasm	9.33e-05	0.000492	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—BCHE—peripheral nervous system neoplasm	8.9e-05	0.000469	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.49e-05	0.000448	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—TH—peripheral nervous system neoplasm	8.37e-05	0.000441	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—GNAS—peripheral nervous system neoplasm	6.83e-05	0.00036	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—ABCB1—peripheral nervous system neoplasm	6.71e-05	0.000353	CbGpPWpGaD
Clodronate—PTGS2—Disease—PTPN11—peripheral nervous system neoplasm	5.67e-05	0.000299	CbGpPWpGaD
Clodronate—PTGS2—Disease—ERBB2—peripheral nervous system neoplasm	4.48e-05	0.000236	CbGpPWpGaD
Clodronate—PTGS2—Disease—NRAS—peripheral nervous system neoplasm	3.41e-05	0.00018	CbGpPWpGaD
Clodronate—PTGS2—Disease—MYC—peripheral nervous system neoplasm	3.18e-05	0.000167	CbGpPWpGaD
Clodronate—PTGS2—Disease—HRAS—peripheral nervous system neoplasm	2.49e-05	0.000131	CbGpPWpGaD
Clodronate—PTGS2—Disease—AKT1—peripheral nervous system neoplasm	2.2e-05	0.000116	CbGpPWpGaD
Clodronate—PTGS2—Metabolism—AKT1—peripheral nervous system neoplasm	1.84e-05	9.72e-05	CbGpPWpGaD
